Akums Drugs and Pharmaceuticals Ltd reports Q2 FY27 consolidated revenue of ₹1,342.4 crore and net profit of ₹114.6 crore
- Revenue rose 31.9% year on year; net profit increased 168.3%.
- Operating margin was 11.3%, versus 5.6% in Q2 FY26.
- Appointed President–Operations Sanjay Kumar as Senior Management Personnel, effective November 2, 2026.
- Auditor noted a disputed ₹156 crore income-tax demand; management said no adjustment was required. No IPO-fund utilisation deviation was reported.